Anales de la RANM

203 A N A L E S R A N M R E V I S T A F U N D A D A E N 1 8 7 9 INFECCIÓN POR HANTAVIRUS Bouza E, et al. An RANM. 2026;143(01): 182 - 206 course of hantavirus-induced nephropathia epidemica in children compared to adults in Germany-analysis of 317 patients. Pediatr Ne- phrol. 2019;34(7):1247-52. 178. Dzagurova TK, Tkachenko EA, Ishmukhame- tov AA, Balovneva MV, Klempa B, Kruger DH. Severe hantavirus disease in children. J Clin Virol. 2018;101:66-8. 179. Ferrés M, Vial P. Hantavirus infection in chil- dren. Curr Opin Pediatr. 2004;16(1):70-5. 180. Pini NC, Resa A, del Jesús Laime G, Lecot G, Ksiazek TG, Levis S, et al. Hantavirus infec- tion in children in Argentina. Emerg Infect Dis. 1998;4(1):85-7. 181. Yoo KH, Choi Y. Haemorrhagic fever with re- nal syndrome in Korean children. Korean So- ciety of Pediatric Nephrology. Pediatr Nephrol. 1994;8(5):540-4. 182. Yang X, Yu C, Chen Y, Nian B, Chai M, Maimaiti D, et al. Hemorrhagic Fever with Renal Syndrome Complicated by Acute Pancreatitis, High Intrao- cular Pressure, and Pulmonary Involvement: a Case Report. Infect Drug Resist. 2024;17:1919-25. 183. Hautala N, Partanen T, Kubin AM, Kauma H, Hautala T. Central Nervous System and Ocular Manifestations in Puumala Hantavirus Infection. Viruses. 2021;13(6). 184. Ranjan R, Ranjan S. Ocular Pathology: Role of Emerging Viruses in the Asia-Pacific Re- gion-A Review. Asia Pac J Ophthalmol (Phila). 2014;3(5):299-307. 185. Hautala N, Kauma H, Rajaniemi SM, Sironen T, Vapalahti O, Pääkkö E, et al. Signs of general in- flammation and kidney function are associated with the ocular features of acute Puumala hantavi- rus infection. Scand J Infect Dis. 2012;44(12):956- 62. 186. Hautala N, Kauma H, Vapalahti O, Mähönen SM, Vainio O, Vaheri A, et al. Prospective study on ocular findings in acute Puumala hantavirus in- fection in hospitalised patients. Br J Ophthalmol. 2011;95(4):559-62. 187. Mehta S, Jiandani P. Ocular features of hantavirus infection. Indian J Ophthalmol. 2007;55(5):378- 80. 188. Kontkanen MI, Puustjärvi TJ, Lähdevirta JK. In- traocular pressure changes in nephropathia epi- demica. A prospective study of 37 patients with acute systemic Puumala virus infection. Ophthal- mology. 1995;102(12):1813-7. 189. Bharadwaj M, Nofchissey R, Goade D, Koster F, Hjelle B. Humoral immune responses in the han- tavirus cardiopulmonary syndrome. J Infect Dis. 2000;182(1):43-8. 190. Ksiazek TG, Peters CJ, Rollin PE, Zaki S, Ni- chol S, Spiropoulou C, et al. Identification of a new North American hantavirus that causes acute pulmonary insufficiency. Am J Trop Med Hyg. 1995;52(2):117-23. 191. Hjelle B. Hantavirus pulmonary syndrome. In: Laboratory Diagnosis of Viral Infections, Len- nette EH, Smith TF (Eds), Marcel Decker, New York . . 1999:Hjelle B. 192. Lee HW. Korean hemorrhagic fever. Prog Med Virol. 1982;28:96-113. 193. Elgh F, Lundkvist A, Alexeyev OA, Stenlund H, Avsic-Zupanc T, Hjelle B, et al. Serologi- cal diagnosis of hantavirus infections by an enzyme-linked immunosorbent assay based on detection of immunoglobulin G and M responses to recombinant nucleocapsid pro- teins of five viral serotypes. J Clin Microbiol. 1997;35(5):1122-30. 194. Kallio-Kokko H, Lundkvist A, Plyusnin A, Av- sic-Zupanc T, Vaheri A, Vapalahti O. Antigenic properties and diagnostic potential of recombi- nant dobrava virus nucleocapsid protein. J Med Virol. 2000;61(2):266-74. 195. Sjölander KB, Elgh F, Kallio-Kokko H, Vapalahti O, Hägglund M, Palmcrantz V, et al. Evaluation of serological methods for diagnosis of Puuma- la hantavirus infection (nephropathia epidemi- ca). J Clin Microbiol. 1997;35(12):3264-8. 196. Vapalahti O, Kallio-Kokko H, Närvänen A, Julkunen I, Lundkvist A, Plyusnin A, et al. Human B-cell epitopes of Puumala vi- rus nucleocapsid protein, the major antigen in early serological response. J Med Virol. 1995;46(4):293-303. 197. Padula PJ, Rossi CM, Valle MOD, Martínez PV, Colavecchia SB, Edelstein A, et al. Deve- lopment and evaluation of a solid-phase enzy- me immunoassay based on Andes hantavirus recombinant nucleoprotein. J Med Microbiol. 2000;49(2):149-55. 198. Tortosa F, Perre F, Tognetti C, Lossetti L, Ca- rrasco G, Guaresti G, et al. Seroprevalen- ce of hantavirus infection in non-epidemic settings over four decades: a systematic re- view and meta-analysis. BMC Public Health. 2024;24(1):2553. 199. Ferrer JF, Jonsson CB, Esteban E, Galligan D, Basombrio MA, Peralta-Ramos M, et al. High prevalence of hantavirus infection in In- dian communities of the Paraguayan and Ar- gentinean Gran Chaco. Am J Trop Med Hyg. 1998;59(3):438-44. 200. Duggan JM. Prevalence of Seoul hantavirus in UK wild rats: an emerging public health pro- blem? Vet Rec. 2019;184(17):523-4. 201. Duggan JM, Close R, McCann L, Wright D, Keys M, McCarthy N, et al. A seroprevalence study to determine the frequency of hantavi- rus infection in people exposed to wild and pet fancy rats in England. Epidemiol Infect. 2017;145(12):2458-65. 202. Yoshimatsu K, Arikawa J. Serological diagnosis with recombinant N antigen for hantavirus in- fection. Virus Res. 2014;187:77-83. 203. Yoshimatsu K, Arikawa J. Antigenic pro- perties of N protein of hantavirus. Viruses. 2014;6(8):3097-109. 204. Pettersson L, Rasmuson J, Andersson C, Ahlm C, Evander M. Hantavirus-specific IgA in sali- va and viral antigen in the parotid gland in pa- tients with hemorrhagic fever with renal syn- drome. J Med Virol. 2011;83(5):864-70. 205. Godoy P, Marsac D, Stefas E, Ferrer P, Tis- chler ND, Pino K, et al. Andes virus antigens are shed in urine of patients with acute han- tavirus cardiopulmonary syndrome. J Virol. 2009;83(10):5046-55. 206. Wang CY, Zhang HH, Yu SL, Zhu CB. Detection of circulating antigen with a MAb-based sand-